Who
Nicole Lambert
Director
Company insider
Files Form 4 as: Director, Arcus Biosciences; Chief Operating Officer, Myriad Genetics.
In numbers
- Trades disclosed
- 60
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $1.1M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 25 Sep 2019
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —5,700 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,900 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,900 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —5,700 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,300 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —13,300 at $0.00 | filing |
| 6 Jun 2024filed 7 Jun 2024 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 6 Jun 2024filed 7 Jun 2024 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —8,400 at $0.00 | filing |
| 9 Oct 2023filed 10 Oct 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $73K4,864 at $15.01 | filing |
| 9 Oct 2023filed 10 Oct 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $109K7,247 at $15.01 | filing |
| 26 Sep 2023filed 27 Sep 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $70K4,402 at $15.99 | filing |
| 15 Jun 2023filed 16 Jun 2023 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,500 at $0.00 | filing |
| 15 Jun 2023filed 16 Jun 2023 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —6,800 at $0.00 | filing |
| 27 Mar 2023filed 28 Mar 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Sold | $151K6,433 at $23.48 | filing |
| 24 Mar 2023filed 27 Mar 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $51K2,143 at $23.72 | filing |
| 24 Mar 2023filed 27 Mar 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $74K3,124 at $23.72 | filing |
| 22 Mar 2023filed 23 Mar 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $55K2,419 at $22.91 | filing |
| 15 Mar 2023filed 16 Mar 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —39,405 at $0.00 | filing |
| 2 Mar 2023filed 3 Mar 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Sold | $300K13,184 at $22.74 | filing |
| 1 Jan 2023filed 4 Jan 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $12K853 at $14.51 | filing |
News
Myriad Genetics (NASDAQ:MYGN) Upgraded at Piper SandlerMYGN · themarketsdaily.com · 23 Oct 2026Myriad Genetics Reports New MRD Detection Data In Colorectal And Pancreatic CancersMYGN · rttnews.com · 22 Oct 2026Financial Review: Myriad Genetics (NASDAQ:MYGN) & AnaptysBio (NASDAQ:ANAB)MYGN · tickerreport.com · 20 Oct 2026
0 headlines in the last 90 days name Nicole Lambert; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.